Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Chao He | President & Executive Director | 1.78M | -- | 1986 |
| Ms. Cong Fang | Executive Director & Board Secretary | 471.45k | -- | 1990 |
| Ms. Xiaoyu Cui | Financial Controller | -- | -- | 1981 |
| Mr. Yu Liu | VP & Chief Commercial Officer | -- | -- | 1970 |
| Ms. Siu Lam Yeung | Company Secretary | -- | -- | -- |
Shanghai MicroPort MedBot (Group) Co., Ltd.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 443
Description
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. It also offers trans-bronchial surgical robots for trans-bronchial diagnosis and treatment. In addition, the company is involved in the manufacture of parts of surgical robot devices; research, development, assembly, and distribution of surgical robot devices; and research and development of system, as well as investment activities. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
Corporate Governance
Upcoming Events
August 28, 2025 at 10:59 AM UTC - September 1, 2025 at 12:00 PM UTC
Shanghai MicroPort MedBot (Group) Co., Ltd. Earnings Date